Browsing Institutt for klinisk medisin by Author "Gaál-Paavola, Emília"

Now showing items 1-2 of 2

  • Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment 
    Skaga, Erlend; Kulesskiy, Evgeny; Brynjulvsen, Marit; Sandberg, Cecilie J; Potdar, Swapnil; Langmoen, Iver A; Laakso, Aki; Gaál-Paavola, Emília; Perola, Markus; Wennerberg, Krister; Vik-Mo, Einar O (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)
    Background Despite the well described heterogeneity in glioblastoma (GBM), treatment is standardized, and clinical trials investigate treatment effects at population level. Genomics-driven oncology for ...
  • Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma 
    Skaga, Erlend; Kulesskiy, Evgeny; Fayzullin, Artem; Sandberg, Cecilie J; Potdar, Swapnil; Kyttälä, Aija; Langmoen, Iver A; Laakso, Aki; Gaál-Paavola, Emília; Perola, Markus; Wennerberg, Krister; Vik-Mo, Einar O (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)
    Background A major barrier to effective treatment of glioblastoma (GBM) is the large intertumoral heterogeneity at the genetic and cellular level. In early phase clinical trials, patient heterogeneity in ...